• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

库欣病缓解的术中预测指标。

Intraoperative Predictor of Remission in Cushing Disease.

机构信息

Department of Neurosurgery, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Department of Neurosurgery, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.

出版信息

Oper Neurosurg (Hagerstown). 2023 Apr 1;24(4):460-467. doi: 10.1227/ons.0000000000000560. Epub 2022 Dec 19.

DOI:10.1227/ons.0000000000000560
PMID:36701661
Abstract

BACKGROUND

Cushing disease represents a challenge for neurosurgeons, with high recurrence rates reported. Characteristics associated with remission are incompletely understood; thus, an intraoperative predictor for outcome would be valuable for assessing resection of adrenocorticotropic hormone (ACTH) secreting tissue.

OBJECTIVE

To evaluate whether intraoperative ACTH measurement could predict outcome after surgery for Cushing disease.

METHODS

Retrospective cohort study of 55 consecutive encounters with Cushing disease who had peripheral plasma ACTH levels measured intraoperatively before, during, and after tumor resection. The primary outcome measure was remission, defined by either 2 negative 24-hour urine free cortisol or 2 negative midnight salivary cortisol measurements. A logistic regression machine learning model was generated using recursive feature elimination.

RESULTS

Fifty-five operative encounters, comprising 49 unique patients, had a mean follow-up of 2.73 years (±2.11 years) and a median follow-up of 2.07 years. Remission was achieved in 69.1% (n = 38) of all operations and in 78.0% (n = 32) of those without cavernous sinus invasion. The final ACTH level measured intraoperatively correctly predicted outcome (area under the curve = 0.766; P value = .002). The odds ratio of remission in patients with the lowest quartile vs highest quartile final intraoperative ACTH was 23.4 ( P value = .002). Logistic regression machine learning model resulted in incorporating postoperative day 1 morning cortisol, final intraoperative ACTH that predicted outcome with an average area under the curve of 0.80 ( P = .0027).

CONCLUSION

Intraoperative ACTH may predict outcome after surgery in Cushing disease; furthermore, investigation is warranted.

摘要

背景

库欣病对神经外科医生来说是一个挑战,据报道其复发率较高。与缓解相关的特征尚未完全理解;因此,对于评估促肾上腺皮质激素(ACTH)分泌组织的切除,术中的预测指标将是有价值的。

目的

评估术中 ACTH 测量是否可以预测库欣病手术后的结果。

方法

对 55 例连续的库欣病患者进行回顾性队列研究,这些患者在肿瘤切除前、切除中和切除后进行外周血浆 ACTH 水平的术中测量。主要结局指标是缓解,定义为 2 次 24 小时尿游离皮质醇或 2 次午夜唾液皮质醇检测均为阴性。使用递归特征消除生成逻辑回归机器学习模型。

结果

55 次手术,包含 49 例患者,平均随访 2.73 年(±2.11 年),中位数随访 2.07 年。所有手术中缓解率为 69.1%(n = 38),无海绵窦侵犯者为 78.0%(n = 32)。术中测量的最终 ACTH 水平正确预测了结果(曲线下面积=0.766;P 值=0.002)。最低四分位术中最终 ACTH 与最高四分位患者的缓解率之比为 23.4(P 值=0.002)。逻辑回归机器学习模型纳入术后第 1 天早晨皮质醇和预测结果的最终术中 ACTH,平均曲线下面积为 0.80(P=0.0027)。

结论

术中 ACTH 可能预测库欣病手术后的结果;因此,值得进一步研究。

相似文献

1
Intraoperative Predictor of Remission in Cushing Disease.库欣病缓解的术中预测指标。
Oper Neurosurg (Hagerstown). 2023 Apr 1;24(4):460-467. doi: 10.1227/ons.0000000000000560. Epub 2022 Dec 19.
2
Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.经蝶窦手术治疗病理确诊的库欣病患者的缓解率、皮质醇、ACTH 评估及即刻再次手术的作用:一项大型单中心经验。
Pituitary. 2013 Dec;16(4):452-8. doi: 10.1007/s11102-012-0455-z.
3
Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.基于组织的 ACTH 抗体检测指导下的经蝶窦切除术治疗库欣病垂体腺瘤的长期疗效。
J Neurosurg. 2018 Sep;129(3):629-641. doi: 10.3171/2017.3.JNS162245. Epub 2017 Oct 13.
4
Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.术后第 1 天清晨皮质醇值作为预测库欣病长期缓解的生物标志物。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e94-e102. doi: 10.1210/clinem/dgaa773.
5
Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.术后早期皮质醇和促肾上腺皮质激素标准化值可预测库欣病手术后的未缓解情况。
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2179-2187. doi: 10.1210/jc.2016-3908.
6
An early post-operative ACTH suppression test can safely predict short- and long-term remission after surgery of Cushing's disease.早期术后促肾上腺皮质激素(ACTH)抑制试验可安全预测库欣病手术后的短期和长期缓解。
Pituitary. 2018 Oct;21(5):490-498. doi: 10.1007/s11102-018-0902-6.
7
Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.库欣病的诊断陷阱:105 例患者的手术缓解率、检测阈值及经验教训。
J Clin Endocrinol Metab. 2022 Jan 1;107(1):205-218. doi: 10.1210/clinem/dgab659.
8
Prediction of recurrence and remission within 3 years in patients with Cushing disease after successful transnasal adenomectomy.预测库欣病患者经鼻蝶窦腺瘤切除术成功治疗后 3 年内的复发和缓解情况。
Pituitary. 2019 Dec;22(6):574-580. doi: 10.1007/s11102-019-00985-5.
9
POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.术后复发库欣病:正常尿游离皮质醇患者早期干预的临床获益。
Endocr Pract. 2016 Oct;22(10):1216-1223. doi: 10.4158/EP161380.OR. Epub 2016 Jul 13.
10
Machine learning-based prediction of outcomes of the endoscopic endonasal approach in Cushing disease: is the future coming?基于机器学习的内镜经鼻入路治疗库欣病结局预测:未来已来?
Neurosurg Focus. 2020 Jun;48(6):E5. doi: 10.3171/2020.3.FOCUS2060.

引用本文的文献

1
Specific focus on the basal dura for improving Cushing's disease surgery: a cohort study.专注于硬脑膜基部以改善库欣病手术:一项队列研究。
Neurosurg Rev. 2025 Jun 5;48(1):483. doi: 10.1007/s10143-025-03656-1.